TMED2 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 2.783600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
3.011200E-01
Normal-vs-Stage2
2.820600E-01
Normal-vs-Stage3
6.911400E-01
Normal-vs-Stage4
2.183200E-01
Stage1-vs-Stage2
8.927400E-01
Stage1-vs-Stage3
4.331200E-01
Stage1-vs-Stage4
5.085800E-01
Stage2-vs-Stage3
4.665800E-01
Stage2-vs-Stage4
3.505600E-01
Stage3-vs-Stage4
2.422800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
2.713800E-01
Normal-vs-AfricanAmerican
2.855800E-01
Normal-vs-Asian
8.416200E-01
Caucasian-vs-AfricanAmerican
8.062000E-01
Caucasian-vs-Asian
8.118300E-02
AfricanAmerican-vs-Asian
1.379620E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
2.897600E-01
Normal-vs-Female
2.615000E-01
Male-vs-Female
3.905000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
9.399200E-01
Normal-vs-Age(41-60Yrs)
1.471990E-01
Normal-vs-Age(61-80Yrs)
3.609800E-01
Normal-vs-Age(81-100Yrs)
3.979000E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
1.619150E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
4.006600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
4.089400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
8.798100E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
4.958400E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
5.228200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
4.078800E-01
Normal-vs-Daily Drinker
4.668200E-01
Normal-vs-Weekly Drinker
5.254600E-01
Normal-vs-Occasional Drinker
1.662430E-01
Normal-vs-Social Drinker
3.586200E-01
Non Drinker-vs-Daily Drinker
8.861800E-01
Non Drinker-vs-Weekly Drinker
9.637600E-01
Non Drinker-vs-Occasional Drinker
3.510100E-02
Non Drinker-vs-Social Drinker
3.306400E-01
Daily Drinker-vs-Weekly Drinker
8.851800E-01
Daily Drinker-vs-Occasional Drinker
4.839800E-02
Daily Drinker-vs-Social Drinker
3.740800E-01
Weekly Drinker-vs-Occasional Drinker
7.118200E-02
Weekly Drinker-vs-Social Drinker
3.787600E-01
Occasional Drinker-vs-Social Drinker
3.939000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
3.029400E-01
Normal-vs-Grade 2
1.427170E-01
Normal-vs-Grade 3
1.183430E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
7.922800E-01
Grade 1-vs-Grade 3
8.452000E-01
Grade 1-vs-Grade 4
3.029400E-01
Grade 2-vs-Grade 3
4.488000E-01
Grade 2-vs-Grade 4
1.427170E-01
Grade 3-vs-Grade 4
1.183430E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
4.171200E-01
Normal-vs-NonDiabetic
3.117800E-01
Diabetic-vs-NonDiabetic
4.591200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
5.948600E-01
Normal-vs-NoPancreatitis
3.026000E-01
Pancreatitis-vs-NoPancreatitis
2.612400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
3.145600E-01
Normal-vs-N1
2.715600E-01
N0-vs-N1
9.162600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
1.559180E-01
Normal-vs-TP53-NonMutant
2.364000E-01
TP53-Mutant-vs-TP53-NonMutant
3.927400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
